Related Experiment Videos
High-affinity peptide ligands to prostate-specific antigen identified by polysome selection
G M Gersuk1, M J Corey, E Corey
1Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, USA. ggersuk@cclink.fhcrc.org
Biochemical and Biophysical Research Communications
|March 17, 1997
Summary
Researchers developed a polysome-selection method to find high-affinity peptide ligands for Prostate-Specific Antigen (PSA), a key prostate cancer marker. This technique yields promising tools for potential diagnostic and therapeutic applications in prostate cancer.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Prostate-Specific Antigen (PSA) is a crucial biomarker for prostate cancer.
- Developing high-affinity ligands for PSA is essential for improved diagnostics and therapeutics.
Purpose of the Study:
- To isolate and characterize high-affinity peptide ligands that bind specifically to Prostate-Specific Antigen (PSA).
- To evaluate the efficacy of the polysome-selection method for generating such ligands.
Main Methods:
- Utilized in vitro transcription and translation of two large random peptide libraries.
- Employed polysome-panning via affinity selection against immobilized PSA.
- Assessed binding affinity using dissociation constants and streptavidin conjugation.
Main Results:
- Over 30% of selected peptide species exhibited significant affinity for PSA.
- The highest affinity isolate formed a complex with PSA with a dissociation constant < 10(-9) M.
- Streptavidin conjugation enhanced peptide affinity and reduced non-specific binding.
Conclusions:
- The polysome-selection method is effective for producing high-affinity peptide ligands for PSA.
- These peptide ligands hold potential for advancing prostate cancer diagnostics and therapies.